Integra LifeSciences Holdings Long Term Debt 2012-2026 | IART

Integra LifeSciences Holdings long term debt from 2012 to 2026. Long term debt can be defined as the sum of all long term debt fields.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Integra LifeSciences Holdings Annual Long Term Debt
(Millions of US $)
2025 $1,730
2024 $1,196
2023 $1,485
2022 $1,405
2021 $1,501
2020 $1,408
2019 $1,303
2018 $1,332
2017 $1,781
2016 $665
2015 $700
2014 $626
2013 $392
2012 $520
2011 $532
Integra LifeSciences Holdings Quarterly Long Term Debt
(Millions of US $)
2026-06-30 $1,829
2026-03-31 $1,827
2025-12-31 $1,730
2025-09-30 $1,792
2025-06-30 $1,227
2025-03-31 $1,231
2024-12-31 $1,196
2024-09-30 $1,205
2024-06-30 $1,801
2024-03-31 $1,837
2023-12-31 $1,485
2023-09-30 $1,420
2023-06-30 $1,333
2023-03-31 $1,440
2022-12-31 $1,405
2022-09-30 $1,487
2022-06-30 $1,498
2022-03-31 $1,502
2021-12-31 $1,501
2021-09-30 $1,499
2021-06-30 $1,499
2021-03-31 $1,485
2020-12-31 $1,408
2020-09-30 $1,506
2020-06-30 $1,541
2020-03-31 $1,577
2019-12-31 $1,303
2019-09-30 $1,384
2019-06-30 $1,307
2019-03-31 $1,331
2018-12-31 $1,332
2018-09-30 $1,421
2018-06-30 $1,476
2018-03-31 $1,772
2017-12-31 $1,781
2017-09-30 $1,153
2017-06-30 $868
2017-03-31 $849
2016-12-31 $665
2016-09-30 $659
2016-06-30 $684
2016-03-31 $712
2015-12-31 $700
2015-09-30 $719
2015-06-30 $644
2015-03-31 $611
2014-12-31 $626
2014-09-30 $621
2014-06-30 $631
2014-03-31 $629
2013-12-31 $392
2013-09-30 $545
2013-06-30 $543
2013-03-31 $521
2012-12-31 $520
2012-09-30 $518
2012-06-30 $516
2012-03-31 $523
2011-12-31 $532
2011-09-30 $542
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.222B $1.635B
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $226.884B 25.75
Intuitive Surgical (ISRG) United States $133.518B 45.26
Edwards Lifesciences (EW) United States $49.242B 30.43
IQVIA Holdings (IQV) United States $43.729B 23.39
Waters (WAT) United States $40.283B 29.97
IDEXX Laboratories (IDXX) United States $40.144B 35.83
Alcon (ALC) Switzerland $33.505B 20.78
DexCom (DXCM) United States $31.955B 33.21
Mettler-Toledo (MTD) United States $25.762B 28.65
STERIS (STE) Ireland $20.832B 20.50
SONOVA HOLDING (SONVY) Switzerland $16.759B 0.00
Hologic (HOLX) United States $16.752B 17.53
Coloplast (CLPBY) Denmark $14.762B 17.70
Penumbra (PEN) United States $12.599B 83.08
Fresenius Medical Care AG KGaA (FMS) Germany $12.279B 8.59
Globus Medical (GMED) United States $10.173B 15.40
Glaukos (GKOS) United States $10.092B 0.00
Masimo (MASI) United States $9.578B 30.69
SARTORIUS (SSSGY) Germany $7.521B 43.67
Sysmex ADR (SSMXY) Japan $7.390B 27.95
Teleflex (TFX) United States $5.521B 14.89
LivaNova (LIVN) United Kingdom $4.442B 22.46
Integer Holdings (ITGR) United States $4.287B 19.86
Pulse Biosciences (PLSE) United States $3.752B 0.00
Veracyte (VCYT) United States $3.313B 27.11
TransMedics (TMDX) United States $2.967B 43.58
AxoGen (AXGN) United States $2.354B 0.00
UFP Technologies (UFPT) United States $2.153B 27.17
Elekta AB (EKTAY) Sweden $1.883B 17.62
Nihon Kohden (NHNKY) Japan $1.694B 15.52
Alphatec Holdings (ATEC) United States $1.677B 0.00
Alpha Tau Medical (DRTS) Israel $1.301B 0.00
Artivion (AORT) United States $1.217B 46.24
PROCEPT BioRobotics (PRCT) United States $1.204B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.171B 27.77
Tandem Diabetes Care (TNDM) United States $1.170B 0.00
OPKO Health (OPK) United States $1.164B 0.00
IRadimed (IRMD) United States $1.055B 46.11
Anteris Technologies Global (AVR) Australia $0.850B 0.00
SiBone (SIBN) United States $0.829B 0.00
Beta Bionics (BBNX) United States $0.753B 0.00
Mesa Laboratories (MLAB) United States $0.680B 16.37
AngioDynamics (ANGO) United States $0.641B 0.00
OrthoPediatrics (KIDS) United States $0.583B 0.00
Delcath Systems (DCTH) United States $0.570B 1644.00
Tactile Systems Technology (TCMD) United States $0.511B 20.90
NeuroPace (NPCE) United States $0.501B 0.00
Sight Sciences (SGHT) United States $0.448B 0.00
Pacific Biosciences Of California (PACB) United States $0.420B 0.00
ClearPoint Neuro (CLPT) United States $0.411B 0.00
908 Devices (MASS) United States $0.402B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.371B 0.00
Mobia Medical (MOBI) United States $0.334B 0.00
Semler Scientific (SMLR) United States $0.311B 2.32
Treace Medical Concepts (TMCI) United States $0.301B 0.00
Spectral Diagnostics (EDTXF) Canada $0.266B 0.00
RxSight (RXST) United States $0.254B 0.00
Neuronetics (STIM) United States $0.221B 0.00
Lucid Diagnostics (LUCD) United States $0.159B 0.00
FocalTherics (FOCL) France $0.154B 0.00
Inogen (INGN) United States $0.139B 0.00
EDAP TMS S.A (EDAP) France $0.124B 0.00
Microbot Medical (MBOT) United States $0.097B 0.00
LENSAR (LNSR) United States $0.096B 0.00
Hyperfine (HYPR) United States $0.085B 0.00
Zomedica (ZOMDF) United States $0.083B 0.00
CVRx (CVRX) United States $0.080B 0.00
QT Imaging Holdings (QTIH) United States $0.078B 0.00
Covalon Technologies (CVALF) Canada $0.071B 23.27
DarioHealth (DRIO) United States $0.069B 0.00
Positron (POSC) United States $0.059B 0.00
Rapid Micro Biosystems (RPID) United States $0.059B 0.00
Envoy Medical (COCH) United States $0.056B 0.00
Nano-X Imaging (NNOX) Israel $0.055B 0.00
Spectral AI (MDAI) United States $0.052B 0.00
Sensus Healthcare (SRTS) United States $0.052B 0.00
Precision Optics (POCI) United States $0.048B 0.00
Baird Medical Investment Holdings (BDMD) $0.045B 0.00
InspireMD (NSPR) United States $0.038B 0.00
QT Imaging Holdings (QTI) United States $0.036B 0.00
PAVmed (PAVM) United States $0.035B 0.00
Ekso Bionics Holdings (EKSO) United States $0.032B 0.00
Accuray (ARAY) United States $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.009B 0.00
EnVVeno Medical (NVNO) United States $0.007B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.004B 0.00
Tenon Medical (TNON) United States $0.004B 0.00
ENvue Medical (FEED) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
NexGel (NXGL) United States $0.003B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.000B 0.00
WORK Medical Technology Group (WOK) China $0.000B 0.00